Equipping Pharmacists for Evidence-Based Abortion Medication Access

Pharmacists play an important role in medication abortion care by providing accurate information, counseling, and clinical oversight. In the community setting, pharmacists can educate patients on how mifepristone and misoprostol work, explain potential side effects, ensure appropriate dosing, and serve as a safety checkpoint. Beyond dispensing, pharmacists can contribute to evidence-based care through protocol development, guideline implementation, and advocacy.

To be effective in this role, pharmacists must stay informed and trained. Numerous continuing education programs are available that cover clinical guidance, patient counseling, and legal considerations. Understanding state and federal laws is critical, as legal restrictions vary widely and can impact a pharmacist’s ability to dispense or counsel on medication abortion.

One of the most significant barriers pharmacists face is the shifting legislative landscape. Even though mifepristone is FDA-approved and considered safe, some states restrict or ban its use. These laws may prohibit telehealth abortions, mandate in-person visits, or limit which providers can be involved in abortion care. Staying informed about legislation and advocating for access is essential for pharmacists committed to providing safe, evidence-based medication abortion care.

Drug Topics recently sat down with Nicole Cieri-Hutcherson, PharmD, BCPS, MSCP, FCCP, clinical associate professor at University at Buffalo, to discuss what ways pharmacists can support patient counseling and education around medication abortion, what types of training or continuing education could better prepare pharmacists to safely dispense medication abortion, and the most significant challenges pharmacists might face in implementing medication abortion services.

READ MORE: Pharmacists Play Key Role in Expanding Access to Medication Abortion